CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Spring Pharmaceutical Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Spring Pharmaceutical Group Inc
11 Quanxing Road, Sishui County
Phone: +86 5374268271p:+86 5374268271 Jining, SDG  373200  China Fax: +86 5374268272f:+86 5374268272
On 6/19/2019, the Company filed a Registration Withdrawal Request of its Form S-1 (File No. 333-226179) with the SEC, initially filed with the Commission on July 13, 2018.
This company is no longer actively traded on any major stock exchange.
Business Summary
SPRING PHARMACEUTICAL GROUP, INC., formerly China YCT International Group, Inc., operates through two of its subsidiaries, Landway Nano Bio-Tech Group, Inc. (Landway Nano) and Shandong Spring Pharmaceutical Co., Ltd. (Shandong Spring Pharmaceutical). Through its subsidiaries, the Company is engaged in the distribution of health care supplement products, and in the development, manufacture and sales of Huoliyuan capsules, and in the development of the acer truncatum bunge planting bases and selling acer truncatum seed oil.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20183/31/2018YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer TingheYan 62 1/1/2007 1/1/2007
Chief Financial Officer ChuanmingLi 52 1/1/2010 1/1/2005
Vice President - Shandong Spring Pharmaceutical Co., Ltd ZechengShao 44 1/1/2018 1/1/2007
7 additional Officers and Directors records available in full report.

Business Names
Business Name
CYIG
Landway Nano Bio-Tech Group, Inc
Shandong Spring Pharmaceutical Co., Ltd.

General Information
Number of Employees: 283 (As of 3/31/2012)
Outstanding Shares: 29,839,168 (As of 2/14/2019)
Shareholders: 770
Stock Exchange: OTC
Federal Tax Id: 208737677
Fax Number: +86 5374268272


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023